159 related articles for article (PubMed ID: 18289100)
1. Importance of iron and iron metabolism in nonalcoholic fatty liver disease.
Baptista-Gonzalez H; Chavez-Tapia NC; Zamora-Valdés D; Uribe M; Mendez-Sanchez N
Mini Rev Med Chem; 2008 Feb; 8(2):171-4. PubMed ID: 18289100
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload?
Moirand R; Mendler MH; Guillygomarc'h A; Brissot P; Deugnier Y
J Hepatol; 2000 Dec; 33(6):1024-6. PubMed ID: 11131442
[No Abstract] [Full Text] [Related]
3. Iron overload in nonalcoholic steatohepatitis.
Fujita N; Takei Y
Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
[TBL] [Abstract][Full Text] [Related]
4. Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis.
Ahmed U; Latham PS; Oates PS
World J Gastroenterol; 2012 Sep; 18(34):4651-8. PubMed ID: 23002334
[TBL] [Abstract][Full Text] [Related]
5. Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.
Chitturi S; George J
Curr Gastroenterol Rep; 2003 Feb; 5(1):18-25. PubMed ID: 12530944
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.
Preziosi ME; Singh S; Valore EV; Jung G; Popovic B; Poddar M; Nagarajan S; Ganz T; Monga SP
J Hepatol; 2017 Aug; 67(2):360-369. PubMed ID: 28341391
[TBL] [Abstract][Full Text] [Related]
7. Iron as a co-morbid factor in nonhemochromatotic liver disease.
Bonkovsky HL; Lambrecht RW; Shan Y
Alcohol; 2003 Jun; 30(2):137-44. PubMed ID: 12957298
[TBL] [Abstract][Full Text] [Related]
8. [Involvement and role of iron in nonalcoholic steatohepatitis].
Cojocariu C; Trifan A; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):308-12. PubMed ID: 19294996
[TBL] [Abstract][Full Text] [Related]
9. Iron and steatohepatitis.
Corradini E; Pietrangelo A
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():42-6. PubMed ID: 22320915
[TBL] [Abstract][Full Text] [Related]
10. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
[TBL] [Abstract][Full Text] [Related]
11. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
[TBL] [Abstract][Full Text] [Related]
12. Paying the Iron Price: Liver Iron Homeostasis and Metabolic Disease.
Ameka M; Hasty AH
Compr Physiol; 2022 Jun; 12(3):3641-3663. PubMed ID: 35766833
[TBL] [Abstract][Full Text] [Related]
13. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
Spahr L; Rubbia-Brandt L; Hadengue A
Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004
[TBL] [Abstract][Full Text] [Related]
14. [Non-alcoholic fatty liver disease].
Calderaro J; Zafrani ES
Ann Pathol; 2010 Dec; 30(6):413-20. PubMed ID: 21167426
[No Abstract] [Full Text] [Related]
15. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease.
Kirsch R; Sijtsema HP; Tlali M; Marais AD; Hall Pde L
Liver Int; 2006 Dec; 26(10):1258-67. PubMed ID: 17105592
[TBL] [Abstract][Full Text] [Related]
16. Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes.
Messner DJ; Rhieu BH; Kowdley KV
Dig Dis Sci; 2013 Jul; 58(7):1899-908. PubMed ID: 23558563
[TBL] [Abstract][Full Text] [Related]
17. A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice.
Padda RS; Gkouvatsos K; Guido M; Mui J; Vali H; Pantopoulos K
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G251-61. PubMed ID: 25501544
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil.
Torres DM; Harrison SA
Semin Liver Dis; 2012 Feb; 32(1):30-8. PubMed ID: 22418886
[TBL] [Abstract][Full Text] [Related]
19. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.
Deguti MM; Sipahi AM; Gayotto LC; Palácios SA; Bittencourt PL; Goldberg AC; Laudanna AA; Carrilho FJ; Cançado EL
Braz J Med Biol Res; 2003 Jun; 36(6):739-45. PubMed ID: 12792703
[TBL] [Abstract][Full Text] [Related]
20. A critical evaluation of the role of iron overload in fatty liver disease.
Fernandez M; Lokan J; Leung C; Grigg A
J Gastroenterol Hepatol; 2022 Oct; 37(10):1873-1883. PubMed ID: 35906772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]